RESUMO
This study reports a patient with severe skin disease in the context of profound immunodeficiency explained by two concomitant genetic diseases caused by two novel homozygous loss-of-function mutations in PLEC1 and CARMIL2. The work provides additional information on the clinical and immunological manifestations of CARMIL2 deficiency and highlights the particular diagnostic and therapeutic challenge represented by the concomitant presence of two rare monogenic disorders.
Assuntos
Epidermólise Bolhosa/genética , Síndromes de Imunodeficiência/genética , Proteínas dos Microfilamentos/genética , Plectina/genética , Pré-Escolar , Epidermólise Bolhosa/complicações , Humanos , Síndromes de Imunodeficiência/complicações , Masculino , MutaçãoRESUMO
Infantile haemangioma (IH) are the most frequent skin tumors in childhood. The diagnosis is usually established from the clinical picture and typical course of growth. Sectional imaging procedures are indicated in segmental, especially facial haemangiomas. The vast majority of IH are uncomplicated and do not require any treatment. In complicated IH, treatment should be initiated as soon as possible in order to avoid permanent damage. Propranolol is the treatment of choice for complicated IH.
Assuntos
Hemangioma/tratamento farmacológico , Propranolol/uso terapêutico , Neoplasias Cutâneas/tratamento farmacológico , Criança , Face , Hemangioma/patologia , Humanos , Lactente , Neoplasias Cutâneas/patologia , Resultado do TratamentoRESUMO
The precise classification of epidermolysis bullosa (EB) into 4 main types and more than 30 subtypes is based on the level of skin cleavage, as well as clinical and molecular features, and is crucial for early prognostication, case management, genetic counselling and prenatal or pre-implantation diagnosis. We report here the molecular pathology of 40 consecutive cases of suspected EB, which were investigated by immunofluorescence mapping (IFM) and/or by a targeted next-generation sequencing (NGS) multi-gene panel. IFM correctly established the EB subtype in 76% of cases, while the molecular pathology was completely elucidated in 90% of cases by the targeted NGS multi-gene panel. Thirteen previously unreported mutations in EB genes were identified. In cases with unclear clinical and IFM findings, mutations were found by NGS in previously unexpected genes. IFM was useful in delivering fast results in newborns, and in indicating the consequences of the variants of uncertain significance on protein level. This study underscores the efficacy of the strategy of combining targeted NGS with IFM in resolving unusual EB phenotypes. It also suggests that, despite technological advances, careful clinical evaluation and deep phenotyping remains a crucial factor that dictates successful diagnosis of EB.
Assuntos
Análise Mutacional de DNA , Epidermólise Bolhosa/diagnóstico , Epidermólise Bolhosa/genética , Sequenciamento de Nucleotídeos em Larga Escala , Técnicas de Diagnóstico Molecular , Mutação , Adolescente , Adulto , Biópsia , Criança , Pré-Escolar , Epidermólise Bolhosa/classificação , Epidermólise Bolhosa/imunologia , Imunofluorescência , Marcadores Genéticos , Predisposição Genética para Doença , Alemanha , Humanos , Lactente , Recém-Nascido , Pessoa de Meia-Idade , Fenótipo , Valor Preditivo dos Testes , Reprodutibilidade dos Testes , Pele/imunologia , Pele/patologia , Adulto JovemRESUMO
BACKGROUND: From 18% to 30% of infantile hemangiomas (IH) are located on the extremities (IHE). They can be divided into localized, segmental, and minimal or arrested growth (IH-MAG) subtypes. OBJECTIVE: We sought to correlate localization of IHE with the anatomy of the arterial vascular supply. METHODS: All children with segmental IHE and IH-MAG presenting to our department of pediatric dermatology from 2002 to 2015 were evaluated. Hemangiomas were mapped and their patterns were analyzed. RESULTS: Most IHE were unilateral (105/109). Two thirds (68/109) were located on the upper, and one third (41/109) on the lower extremities. Distal locations were more frequently affected. Segmental IHE were more common (upper extremities 83.8%; lower extremities 56.1%) than IH-MAG (16.2% and 43.9%, respectively). Ulceration occurred in 5.5%. Localization of IHE was found to correspond to supply areas of embryonic arterial variants. LIMITATIONS: This was a retrospective study. Only segmental IHE and IH-MAG were evaluated. Angiographic studies were not performed. CONCLUSION: The location of IHE may be related to variant anatomy of arterial supply during embryo fetal development. We hypothesize that this contributes to temporary regional tissue hypoxia during early fetal development, which is a known stimulus for the proliferation of hemangioma stem cells.
Assuntos
Hemangioma Capilar/epidemiologia , Hemangioma Capilar/patologia , Neoplasias Cutâneas/epidemiologia , Neoplasias Cutâneas/patologia , Malformações Vasculares/diagnóstico , Fatores Etários , Estudos de Coortes , Bases de Dados Factuais , Feminino , Seguimentos , Alemanha , Hemangioma Capilar/diagnóstico , Humanos , Lactente , Recém-Nascido , Extremidade Inferior/anatomia & histologia , Extremidade Inferior/irrigação sanguínea , Masculino , Estudos Retrospectivos , Medição de Risco , Índice de Gravidade de Doença , Fatores Sexuais , Neoplasias Cutâneas/diagnóstico , Extremidade Superior/anatomia & histologia , Extremidade Superior/irrigação sanguíneaRESUMO
BACKGROUND/OBJECTIVES: Multifocal infantile hemangiomas (MIHs; previously called neonatal hemangiomatosis) can be associated with extracutaneous hemangiomas. We observed different morphologic types of hemangiomas in children with MIHs and sought to find out whether they are related to the clinical course. METHODS: This was a retrospective study of 103 infants with MIHs and a control group of 261 age-matched patients with solitary focal infantile hemangiomas (IHs) seen at an academic pediatric dermatology department between 2004 and 2014. RESULTS: Two morphologic subtypes of hemangiomas were identified: miliary focal hemangiomas (MFHs; small, lens shaped) in 58 of 103 MIH patients (56.3%), and classical nonmiliary focal IHs (NMIHs; larger, irregularly shaped) in 17 of 103 patients (16.5%). MIHs featuring both types (mixed type) were observed in 28 of 103 patients (27.2%). MFH lesions were significantly smaller (mean 5.3 mm [range 1-20 mm] vs 22.0 mm [range 2-100 mm]), more numerous (23.4 ± 27.3 [range 5-175] vs 7.4 ± 2.8 [range 5-15] p < 0.001), and occurred up to an older age (6.0 ± 5.8 months [range 0-27 months] vs 3.8 ± 2.6 months [range 0-9 months]) than NMIHs. There was a weakly positive correlation between the number and presence of extracutaneous IHs in children with MFHs. Significantly more children with MIHs were delivered preterm than those with solitary IHs. CONCLUSIONS: The number of IHs correlates inversely with their size. MFHs follow a clinical course different from that of classical IHs, are associated with prematurity, and may confer greater risk of extracutaneous hemangiomas. Miliary hemangiomas thus appear to present a separate IH subset requiring special attention.
Assuntos
Hemangioma Capilar/patologia , Neoplasias Cutâneas/patologia , Estudos de Casos e Controles , Pré-Escolar , Feminino , Hemangioma , Humanos , Lactente , Recém-Nascido , Masculino , Estudos RetrospectivosAssuntos
Processamento Alternativo , Autoantígenos/genética , Epidermólise Bolhosa Juncional/genética , Mutação , Colágenos não Fibrilares/genética , Autoantígenos/metabolismo , Células Cultivadas , Análise Mutacional de DNA , Epidermólise Bolhosa Juncional/diagnóstico , Epidermólise Bolhosa Juncional/metabolismo , Estudos de Associação Genética , Predisposição Genética para Doença , Humanos , Queratinócitos/metabolismo , Colágenos não Fibrilares/metabolismo , Fenótipo , Índice de Gravidade de Doença , Colágeno Tipo XVIIAssuntos
Epidermólise Bolhosa Juncional/terapia , Pele/patologia , Infecções Cutâneas Estafilocócicas/terapia , Cicatrização , Infecção dos Ferimentos/terapia , Antibacterianos/uso terapêutico , Moléculas de Adesão Celular/genética , Criança , Pré-Escolar , Terapia Combinada , Epidermólise Bolhosa Juncional/genética , Epidermólise Bolhosa Juncional/patologia , Feminino , Predisposição Genética para Doença , Humanos , Masculino , Mutação , Fenótipo , Sítios de Splice de RNA , Pele/microbiologia , Transplante de Pele , Infecções Cutâneas Estafilocócicas/microbiologia , Infecções Cutâneas Estafilocócicas/patologia , Esteroides/uso terapêutico , Resultado do Tratamento , Infecção dos Ferimentos/microbiologia , Infecção dos Ferimentos/patologia , CalininaRESUMO
Central processing of acoustic signals is assumed to take place in a stereotypical spatial and temporal pattern involving different fields of auditory cortex. So far, cortical propagating waves representing such patterns have mainly been demonstrated by optical imaging, repeatedly in the visual and somatosensory cortex. In this study, the surface of rat auditory cortex was mapped by recording local field potentials (LFPs) in response to a broadband acoustic stimulus. From the peak amplitudes of LFPs, cortical activation maps were constructed over 4 cortical auditory fields. Whereas response onset had same latencies across primary auditory field (A1), anterior auditory field (AAF), and ventral auditory field and longer latencies in posterior auditory field, activation maps revealed a reproducible wavelike pattern of activity propagating for â¼45 ms poststimulus through all cortical fields. The movement observed started with 2 waves within the primary auditory fields A1 and AAF moving from ventral to dorsal followed by a motion from rostral to caudal, passing continuously through higher-order fields. The pattern of propagating waves was well reproducible and showed only minor changes if different anesthetics were used. The results question the classical "hierarchical" model of cortical areas and demonstrate that the different fields process incoming information as a functional unit.
Assuntos
Córtex Auditivo/fisiologia , Vias Auditivas/fisiologia , Percepção Auditiva/fisiologia , Ondas Encefálicas/fisiologia , Potenciais Evocados Auditivos/fisiologia , Estimulação Acústica/métodos , Animais , Córtex Auditivo/anatomia & histologia , Vias Auditivas/anatomia & histologia , Masculino , RatosRESUMO
BACKGROUND: Rare diseases affect approximately 30 million people in the European Union and present a major health issue. Over 1000 rare skin diseases are known, many of which are of genetic origin and manifest in childhood. One of these diseases is epidermolysis bullosa (EB), a genodermatosis presenting with skin fragility and blistering. With an estimate of up to 2000 affected individuals in Germany, many of these children, but only two specialist centres, the question arose where and how health care for this rare disease is provided. This question was addressed by an online survey of all paediatric and dermatological departments in Germany. RESULTS: The response rate was 40.5% (203/501), and 39 departments confirmed treating EB (7.8% of the units addressed). Health care for individuals with EB was provided both by dermatological and paediatric departments (19.8 and 4.2% respectively). The geographic distribution of EB health care was uneven. The two EB centres in Hanover and Freiburg treated 70 and 113 patients, two other departments saw 11 to 20 patients, while the majority saw less than 10 patients annually. There existed large variations between 1. the consultation setting, time frame and frequency, 2. the recommended examinations and check-ups and 3. the diagnostics used to establish the diagnosis. Over 50% of participating physicians were dissatisfied with health care outside of hospitals and more than 20% with their patients' supply with bandages or medications. CONCLUSIONS: The survey results show that health care for individuals with EB in Germany is provided multidisciplinarily. Approaches to diagnostics and follow-up recommendations are heterogeneous and national guidelines are lacking. Functioning and innovative political structures are needed to improve networking and strengthening specialised centres to meet the special needs of individuals with EB and other rare diseases.
Assuntos
Epidermólise Bolhosa/epidemiologia , Doenças Raras/epidemiologia , Criança , Atenção à Saúde , Alemanha/epidemiologia , HumanosRESUMO
Genetic conditions affecting the skin and kidney are clinically and genetically heterogeneous, and target molecular components present in both organs. The molecular pathology involves defects of cell-matrix adhesion, metabolic or signaling pathways, as well as tumor suppressor genes. This article gives a clinically oriented overview of this group of disorders, highlighting entities which have been recently described, as well as the progress made in understanding well-known entities. The genetic bases as well as molecular cell biological mechanisms are described, with therapeutic applications.